You are here

Amy Hoth Warriner, MD

Amy Hoth Warriner, MD
Associate Professor
Department of Medicine
Division of Endocrinology, Diabetes & Metabolism
University of Alabama School of Medicine
510 20th Street South, Suite 758
Birmingham, Alabama 35294-3407
Phone: (205) 975-5786
Fax: (205) 975-9304


  • 7/1998 – 5/2002
    M.D., University of Arkansas for Medical Sciences
  • 8/1994 –5/1998
    B.A., Wartburg College, Waverly, Iowa


  1. Warriner A,   Curtis JR,  Saag KG.  Challenges in defining and improving osteoporosis quality of care.  Cli Exp Rheumatol.  2007;  25 (6 Suppl  47):  142-6.
  2. Warriner A, Saag KG.  The use of zoledronic acid for osteoporosis.Curr Rheumatol Rep. 2008;10(2):89-91.
  3. Teng GG, Warriner A, Curtis JR, Saag KG.  Improving quality of care in osteoporosis: Opportunities and challenges.  Current Rheumatology Reports. 2008; 10(2): 123-130.
  4. Warriner A,  Saag KG.  Theraputic Advances in Calcium and Vitamin D for Osteoporosis.  Current Rheumatology Reports.  2008; 10(2): 90-1.
  5. Curtis JR, Taylor AJ, Matthews RS, Ray MN, Becker DJ, Gary LC, Kilgore ML, Morrisey MA, Saag KG, Warriner A, Delzell E. "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures? Osteoporos Int. 2009 Nov; 20(11): 1969-72.
  6. Warriner AH, Outman RC, Saag KG, Berry SD, Colón-Emeric C, Flood KL, Lyles KW, Tanner SB, Watts NB, Curtis JR. Management of osteoporosis among home health and long-term care patients with a prior fracture. South Med J. 2009 Apr;102(4):397-404.
  7. Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol. 2009 Jul;21(4):356-62.
  8. Warriner AH, Mugavero MJ.  Bone changes and fracture risk in individuals infected with HIV.  Curr Rheumatol Rep. 2010 Jun;12(3):163-9.
  9. Aaron E, Kempf MC, Criniti S, Tedaldi E, Gracely E, Warriner A, Kumar R, Bachmann LH. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication. PLoS One. 2010 Sep 7;5(9):e12617.
  10. Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc. 2010 Oct;11(8):584-91.
  11. Warriner AH, Patkar N, Curtis JR, Delzell E, Gary L, Kilgore M, Morrissey M, Saag KG.  Which Fractures Are Most Attributable to Osteoporosis?. J Clin Epi. 2011 Jan;64(1):46-53.
  12. Warriner AH, Patkar NM, Yun H, Delzell E. Minor, Major, Low-Trauma, and High-Trauma Fractures: What Are the Subsequent Fracture Risks and How Do They Vary? Curr Osteoporos Rep. 2011 Jun 23.
  13. Saag KG, Mohr PE, Esmail L, Mudano AS, Wright N, Beukelman T, Curtis JR, Cutter G, Delzell E, Gary LC, Harrington TM, Karkare S, Kilgore ML, Lewis CE, Moloney R, Oliveira A, Singh HA, Warriner AH, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemporary Clinical Trials. 2012 Nov; 33(6): 1211-6.
  14. Warriner AH, Outman R, Kitchin E, Chen L, Morgan SL, Saag KG, Curtis JR.  A Randomized Trial of a Mailed Intervention and Self-Scheduling to Improve Osteoporosis Screening in Postmenopausal Women. J Bone Miner Res. 2012 Dec; 27(12): 2603-10.
  15. Bowling CB, Muntner P, Bradbury BD, Kilpatrick RD, Isitt JJ, Warriner AH, Curtis JR, Judd S, Brown CJ, Allman RM, Warnock DG McClellan W. Low Hemoglobin and Recurrent Falls in US Men and Women: Prospective findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort. Am J Med Sci. 2013 Jan 16. Epub.
  16. Warriner AH, Saag KG. Osteoporosis Diagnosis and Medical Treatment. Orthopedic Clinics of North America. 2013. April; 44(2): 125-35.
  17. Wright NC, Warriner AH, Saag KG. Study design considerations for a large simple trial of bisphosphonates. Curr Opin Rheumatol. 2013 Jul;25(4):517-23.
  18. Mudano AS, Gary LC, Oliveira AL, Melton M, Wright NC, Curtis JR, Delzell E, Harrington TM, Kilgore ML, Lewis CE, Singh JA, Warriner AH, Pace WD, Saag KG. Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: feasibility, satisfaction, and sample size.Patient Prefer Adherence. 2013 Jun 14(7):517-23.
  19. Saag KG, Curtis J, Warriner A. Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect. J Rheumatol.2013 Oct;40(10):1640-2. PMID: 24085752.
  20. Warriner AH, Saag KG. Prevention and treatment of bone changes associated with exposure to glucocorticoids. Curr Osteoporos Rep. 2013 Dec;11(4):341-7. PMID: 24097304; PMC4047972.
  21. Warriner AH, Saag KG. Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids. Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):510-6. PMID: 24468753.
  22. Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG. Effect of self-referral on bone mineral density testing and osteoporosis treatment. Med Care. 2014 Aug;52(8):743-50. PMID: 24984211; PubMed Central PMCID: PMC4101066.
  23. Zhao D, Shi Z, Warriner AH, Qiao P, Hong H, Wang Y, Feng X. Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis. PLoS One. 2014 Jul 17;9(7):e102706. PMID: 25032991; PMCID: PMC4102552.
  24. Warriner AH, Mugavero M, Overton ET. Bone alterations associated with HIV. Curr HIV/AIDS Rep. 2014 Sep;11(3):233-40. PMID: 25064454.
  25. Warriner AH, Outman RC, Allison JJ, Curtis JR, Markward NJ, Redden DT, Safford MM, Stanek EJ, Steinkellner AR, Saag KG. An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users. J Rheumatol. 2015 Aug;42(8):1478-83.
  26. Warriner AH, Burkholder GA, Overton ET. HIV-related metabolic comorbidities in the current ART era. Infect Dis Clin North Am. 2014 Sep;28(3):457-76. PMID: 25151566.
  27. Duran L, Rodriguez C, Drozd D, Nance RM, Delaney JA, Burkholder G, Mugavero MJ, Willig JH, Warriner AH, Crane PK, Atkinson BE, Harrington RD, Dhanireddy S, Saag MS, Kitahata MM, Crane HM. Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels. AIDS Res Treat. 2015; 2015:478750 Epub 2015 Jul 26.
  28. Negredo E, Warriner AH. Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients. Curr Opin HIV AIDs. 2016 May; 11(3):351-7.